What predicts early volumetric edema increase following stereotactic radiosurgery for brain metastases?

Journal of Neuro-Oncology

Volumn 127, Issue 2, 2016, Pages 303-311

  Hanna, Andrew ^a   Boggs, D Hunter ^b   Kwok, Young ^b   Simard, Marc ^b   Regine, William F ^b   Mehta, Minesh ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Brain; Edema; Metastasis; Radiographic; Radiosurgery; Volume

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN METASTASIS; BRAIN SIZE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; STEREOTACTIC RADIOSURGERY; TREATMENT OUTCOME; TUMOR VOLUME; ADVERSE EFFECTS; BRAIN NEOPLASMS; CANCER STAGING; DIAGNOSTIC IMAGING; EDEMA; FOLLOW UP; MIDDLE AGED; NEOPLASMS; PATHOLOGY; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDY; SECONDARY; STATISTICAL MODEL; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; EDEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM STAGING; NEOPLASMS; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84959911767     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-015-2034-4     Document Type: Article

References (33)

1. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control 19:716–723
2. Boggs DH, Simard JM, Steven A, Mehta MP (2014) Potential of glyburide to reduce intracerebral edema in brain metastases. Expert Rev Neurother 14(4):379–388
3. Boothe D, Young R, Yamada Y, Prager A, Chan T, Beal K (2013) Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery. Neuro Oncol 15:1257–1263. doi:10.1093/neuonc/not085
4. Cabrera AR, Cuneo KC, Desjardins A, Sampson JH, McSherry F, Herndon JE II, Peters KB, Allen K, Hoang JK, Chang Z (2013) Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial. Int J Radiat Oncol Biol Phys 86:873–879
5. Chen M, Dong Y, Simard JM (2003) Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. J Neurosci 23:8568–8577
6. DeAngelis LM, Posner JB, Posner JB (2009) Neurologic complications of cancer. Oxford University Press, New York
7. Deibert CP, Ahluwalia MS, Sheehan JP, Link MJ, Hasegawa T, Yomo S, Feng WH, Li P, Flickinger JC, Lunsford LD (2013) Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery. J Neurooncol 115:217–223
8. Gerstner ER, Duda DG, di Tomaso E, Ryg PA, Loeffler JS, Sorensen AG, Ivy P, Jain RK, Batchelor TT (2009) VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer. Nat Rev Clin Oncol 6:229–236
9. Hanson PW, Elaimy AL, Lamoreaux WT, Demakas JJ, Fairbanks RK, Mackay AR, Taylor B, Cooke BS, Thumma SR, Lee CM (2012) A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases. World J Surg Oncol 10:176. doi:10.1186/1477-7819-10-176
10. Hauswald H, Dittmar J, Habermehl D, Rieken S, Sterzing F, Debus J, Combs SE (2012) Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma. Radiat Oncol 7:130
11. Kano H, Iyer A, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD (2011) Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases. Neurosurgery 69:1232–1239
12. Linskey ME, Andrews DW, Asher AL, Burri SH, Kondziolka D, Robinson PD, Ammirati M, Cobbs CS, Gaspar LE, Loeffler JS (2010) The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:45–68
13. Lippitz B, Lindquist C, Paddick I, Peterson D, O’Neill K, Beaney R (2014) Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev 40(1):48–59
14. Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R et al (2003) Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21:2529–2536. doi:10.1200/JCO.2003.12.122
15. Melisko ME, Kunwar S, Prados M, Berger MS, Park JW (2005) Brain metastases of breast cancer. Expert Rev Anticancer Ther 5:253–268. doi:10.1586/14737140.5.2.253
16. Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48–54
17. Nico B, Ribatti D (2011) Role of aquaporins in cell migration and edema formation in human brain tumors. Exp Cell Res 317:2391–2396
18. Ollerenshaw M, Page T, Hammonds J, Demaine A (2004) Polymorphisms in the hypoxia inducible factor-1α gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet 153:122–126
19. Park J, Qiao L, Su Z, Hinman D, Willoughby K, McKinstry R, Yacoub A, Duigou GJ, Young CS, Grant S (2001) Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways. Oncogene 20(25):3266–3280
20. Ryken TC, McDermott M, Robinson PD, Ammirati M, Andrews DW, Asher AL, Burri SH, Cobbs CS, Gaspar LE, Kondziolka D (2010) The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:103–114
21. Saadoun S, Papadopoulos MC, Davies DC, Krishna S, Bell BA (2002) Aquaporin-4 expression is increased in oedematous human brain tumours. J Neurol Neurosurg Psychiatry 72:262–265
22. Sharma M, Abraham J (2007) CNS metastasis in primary breast cancer. Expert Rev Anticancer Ther 7(11):1561–1566
23. Shibata S (1989) Ultrastructure of capillary walls in human brain tumors. Acta Neuropathol 78:561–571
24. Simard JM, Chen M, Tarasov KV, Bhatta S, Ivanova S, Melnitchenko L, Tsymbalyuk N, West GA, Gerzanich V (2006) Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke. Nat Med 12:433–440
25. Simard JM, Geng Z, Woo SK, Ivanova S, Tosun C, Melnichenko L, Gerzanich V (2009) Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab 29:317–330
26. Simard JM, Kilbourne M, Tsymbalyuk O, Tosun C, Caridi J, Ivanova S, Keledjian K, Bochicchio G, Gerzanich V (2009) Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. J Neurotrauma 26:2257–2267
27. Spanberger T, Berghoff AS, Dinhof C, Ilhan-Mutlu A, Magerle M, Hutterer M, Pichler J, Wöhrer A, Hackl M, Widhalm G (2013) Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases. Clin Exp Metastasis 30:357–368
28. Stamatovic S, Dimitrijevic O, Keep R, Andjelkovic A (2006) Inflammation and brain edema: new insights into the role of chemokines and their receptors. In: Anonymous brain edema XIII. Springer, Berlin, pp 444–450
29. Thompson EM, Pishko GL, Muldoon LL, Neuwelt EA (2013) Inhibition of SUR1 decreases the vascular permeability of cerebral metastases. Neoplasia 15:535
30. Walcott BP, Kahle KT, Simard JM (2012) Novel treatment targets for cerebral edema. Neurotherapeutics 9:65–72
31. Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M (2008) Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther 7:3129–3140. doi:10.1158/1535-7163.MCT-08-0013
32. Yang HC, Kano H, Lunsford LD, Niranjan A, Flickinger JC, Kondziolka D (2011) What factors predict the response of larger brain metastases to radiosurgery? Neurosurgery 68:682
33. Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159:702–706